What's New/
Latest news
- All
- Advocacy
- Experiences
- Guest Blog
- Information
- Research
- Reviews
All
- All
- Advocacy
- Experiences
- Guest Blog
- Information
- Research
- Reviews
Migraine Foundation submits application to Pharmac to fund Emgality
Press release Migraine Foundation Aotearoa New Zealand has submitted a consumer application to Pharmac to ...
Read More
Managing Your Migraine: Book review
Dr Katy Munro from the National Migraine Centre in the UK published a book in ...
Read More
The Painful Truth: Book review
The Painful Truth: The New Science of Why We Hurt and How We Can Heal. ...
Read More
New Zealand health survey data – a decade to be released
Have you ever been told by a doctor you have migraines [sic]? This is what ...
Read More
Biofeedback: an underused migraine treatment
There’s a treatment for migraine that is safe, has no side effects and may work ...
Read More
I tried Aimovig for six months. Here’s my verdict
Calcitonin gene-related peptide or CGRP for short. That’s the target of most of the new ...
Read More
Anxiety and migraine
Do you have trouble relaxing? Are you unable to control or stop worrying? Feel nervous, ...
Read More
Emgality Frequently Asked Questions (FAQs)
In September 2022, the second calcitonin gene-related monoclonal (CGRP) monoclonal antibody medication called Emgality (galcanezumab) ...
Read More
The link between migraine and depression
For Mental Health Awareness Week, we want to highlight that people with migraine disease are ...
Read More
Few people on a benefit for migraine in New Zealand
If you’ve ever wondered how many people in Aotearoa New Zealand are on a benefit ...
Read More
Medication-overuse headache
How do you balance taking acute migraine medications as soon as you feel a migraine ...
Read More
Gepants – more migraine drugs we’re missing out on
The new vogue of migraine medications are those that block calcitonin gene-related peptide (CGRP), a ...
Read More